EUVIMEDEUVIMED entdecken
Crossref

New Ways to Protect the Host from SARS-CoV-2? Lung Microbiome Metabolites Inhibit STAT3 and Modulate the Immunological Network

Jency Roshni, Mahema Sivakumar, Faris Ahmed Bahammam, Shilpa Bhandi, Shankargouda Patil, Manjunath Kamath, Ali Abusharha, Shiek S S J Ahmed iD

OMICS: A Journal of Integrative Biology · 01.05.2023 · 27 (5) · 237-244

DOI: 10.1089/omi.2023.0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OMICS: A Journal of Integrative Biology, online erschienen am 17.05.2023. Verfasst von Jency Roshni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery and Multi-omics Lab, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and E…. Hauptthemen laut MEDLINE: COVID-19, Microbiota. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19 caused by the SARS-CoV-2 infection is a systemic disease that affects multiple organs, biological pathways, and cell types. A systems biology approach would benefit the study of COVID-19 in the pandemic as well as the endemic state. Notably, patients with COVID-19 have dysbiosis of lung microbiota whose functional relevance to the host is largely unknown. We carried out a systems biology investigation of the impact of lung microbiome-derived metabolites on host immune system during COVID-19. RNAseq was performed to identify the host-specific pro- and anti-inflammatory differentially expressed genes (DEGs) in bronchial epithelium and alveolar cells during SARS-CoV-2 infection. The overlapping DEGs were harnessed to construct an immune network while their key transcriptional regulator was deciphered. We identified 68 overlapping genes from both cell types to construct the immune network, and Signal Transducer and Activator of Transcription 3 (STAT3) was found to regulate the majority of the network proteins. Furthermore, thymidine diphosphate produced from the lung microbiome had the highest affinity with STAT3 (−6.349 kcal/mol) than the known STAT3 inhibitors ( n = 410), with an affinity ranging from −5.39 to 1.31 kcal/mol. In addition, the molecular dynamic studies showed distinguishable changes in the behavior of the STAT3 complex when compared with free STAT3. Overall, our results provide new observations on the importance of lung microbiome metabolites that regulate the host immune system in patients with COVID-19, and may open up new avenues for preventive medicine and therapeutics innovation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19MicrobiotaHumansSARS-CoV-2STAT3 Transcription FactorLung

Stichwörter der Autor:innen

COVID-19biomarkersdrug discoveryimmune networkslung microbiomeplanetary health

Substanzen

STAT3 Transcription FactorSTAT3 protein, human

Autor:innen und Institutionen

  • Drug Discovery and Multi-omics Lab, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, India.
  • Fellow Rhinology and Facial Plastics, Imperial College London, London, United Kingdom.
  • College of Dental Medicine, Roseman University of Health Sciences, South Jordan, Utah, USA.
  • Department of Cariology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
  • Centre of Molecular Medicine and Diagnostics (COMManD), Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
  • Centre for Advance Studies, Sathyabama Institute of Science and Technology, Tamil Nadu, Chennai, India.

ORCID-Profile: Shiek S S J Ahmed

Zitieren

APA

Roshni, J., Sivakumar, M., Bahammam, F. A., Bhandi, S., Patil, S., Kamath, M., Abusharha, A., & Ahmed, S. S. S. J. (2023). New Ways to Protect the Host from SARS-CoV-2? Lung Microbiome Metabolites Inhibit STAT3 and Modulate the Immunological Network. OMICS: A Journal of Integrative Biology, 27(5), 237-244. https://doi.org/10.1089/omi.2023.0002

Vancouver

Roshni J, Sivakumar M, Bahammam FA, Bhandi S, Patil S, Kamath M, et al. New Ways to Protect the Host from SARS-CoV-2? Lung Microbiome Metabolites Inhibit STAT3 and Modulate the Immunological Network. OMICS: A Journal of Integrative Biology. 2023;27(5):237-244. doi:10.1089/omi.2023.0002

BibTeX
@article{Roshni2023,
  author = {Roshni, Jency and Sivakumar, Mahema and Bahammam, Faris Ahmed and Bhandi, Shilpa and Patil, Shankargouda and Kamath, Manjunath and Abusharha, Ali and Ahmed, Shiek S S J},
  title = {New Ways to Protect the Host from SARS-CoV-2? Lung Microbiome Metabolites Inhibit STAT3 and Modulate the Immunological Network},
  journal = {OMICS: A Journal of Integrative Biology},
  year = {2023},
  volume = {27},
  number = {5},
  pages = {237--244},
  doi = {10.1089/omi.2023.0002}
}
Kostenlos starten →